相似文献
1
Cardiovascular and hypokalaemic effects of inhaled salbutamol, fenoterol, and isoprenaline.
Thorax. 1989 Feb;44(2):136-40. doi: 10.1136/thx.44.2.136.
2
A comparison of the cardiovascular and metabolic effects of formoterol, salbutamol and fenoterol.
Eur Respir J. 1993 Feb;6(2):204-10.
3
Nebulized fenoterol causes greater cardiovascular and hypokalaemic effects than equivalent bronchodilator doses of salbutamol in asthmatics.
Respir Med. 1992 Sep;86(5):419-23. doi: 10.1016/s0954-6111(06)80009-0.
4
The extrapulmonary effects of inhaled hexoprenaline and salbutamol in healthy individuals.
Eur J Clin Pharmacol. 1993;45(1):37-9. doi: 10.1007/BF00315347.
5
The cardiovascular effects of beta adrenergic agonist drugs administered by nebulisation.
Postgrad Med J. 1990 Feb;66(772):98-101. doi: 10.1136/pgmj.66.772.98.
6
Comparison of hypokalaemic, electrocardiographic and haemodynamic responses to inhaled isoprenaline and salbutamol in young and elderly subjects.
Eur J Clin Pharmacol. 1991;40(3):255-60. doi: 10.1007/BF00315205.
7
Partial vs full beta-receptor agonism. A clinical study of inhaled albuterol and fenoterol.
Chest. 1996 Apr;109(4):957-62. doi: 10.1378/chest.109.4.957.
8
Single dosing comparison of the relative cardiac beta 1/beta 2 activity of inhaled fenoterol and salbutamol in normal subjects.
Thorax. 1993 Jun;48(6):656-8. doi: 10.1136/thx.48.6.656.
9
A comparison of the haemodynamic and hypokalaemic effects of inhaled pirbuterol and salbutamol.
N Z Med J. 1990 Jun 13;103(891):259-61.
10
Hypokalaemia and other non-bronchial effects of inhaled fenoterol and salbutamol: a placebo-controlled dose-response study in healthy volunteers.
Br J Clin Pharmacol. 1987 Nov;24(5):645-53. doi: 10.1111/j.1365-2125.1987.tb03224.x.
引用本文的文献
1
A Comparison of the Molecular Pharmacological Properties of Current Short, Long, and Ultra-Long-Acting β-Agonists Used for Asthma and COPD.
Pharmacol Res Perspect. 2025 Oct;13(5):e70154. doi: 10.1002/prp2.70154.
2
Inhaled salbutamol induces leanness in well-trained healthy females but not males during a period of endurance training: a randomised controlled trial.
ERJ Open Res. 2023 Dec 27;9(6). doi: 10.1183/23120541.00657-2023. eCollection 2023 Nov.
3
Asthma and COPD: A Focus on β-Agonists - Past, Present and Future.
Handb Exp Pharmacol. 2024;285:369-451. doi: 10.1007/164_2023_679.
4
Inhaled Short-Acting Beta Agonist Treatment-Associated Supraventricular Tachycardia in Children: Still a Matter of Concern in Pediatric Emergency Departments?
Children (Basel). 2023 Apr 8;10(4):699. doi: 10.3390/children10040699.
5
Salbutamol-induced electrophysiological changes show no correlation with electrophysiological changes during hyperinsulinaemic-hypoglycaemic clamp in young people with Type 1 diabetes.
Diabet Med. 2018 Apr 23;35(9):1264-72. doi: 10.1111/dme.13650.
6
Short-term safety and tolerability of double-dose salmeterol/fluticasone propionate in adult asthmatic patients.
Clin Drug Investig. 2005;25(4):231-41. doi: 10.2165/00044011-200525040-00002.
7
Current issues with beta2-adrenoceptor agonists: historical background.
Clin Rev Allergy Immunol. 2006 Oct-Dec;31(2-3):107-18. doi: 10.1385/CRIAI:31:2:107.
8
Inhaled beta2-adrenoceptor agonists: cardiovascular safety in patients with obstructive lung disease.
Drugs. 2005;65(12):1595-610. doi: 10.2165/00003495-200565120-00001.
9
Studies on the bronchodilator, tremorogenic, cardiovascular and hypokalaemic effects of fenoterol dry powder in asthma.
Br J Clin Pharmacol. 1993 Oct;36(4):285-92. doi: 10.1111/j.1365-2125.1993.tb00366.x.
10
Inhibition by fenoterol of human eosinophil functions including beta2-adrenoceptor-independent actions.
Clin Exp Immunol. 2002 Dec;130(3):415-23. doi: 10.1046/j.1365-2249.2002.01997.x.
本文引用的文献
1
Effects of atropine on diastolic time.
Circulation. 1981 Feb;63(2):371-7. doi: 10.1161/01.cir.63.2.371.
2
Some statistical methods useful in circulation research.
Circ Res. 1980 Jul;47(1):1-9. doi: 10.1161/01.res.47.1.1.
3
Cardiopulmonary effects of fenoterol and salbutamol aerosols.
Chest. 1980 Mar;77(3):429-31. doi: 10.1378/chest.77.3.429.
4
Nebulised salbutamol and angina.
Br Med J (Clin Res Ed). 1982 Sep 18;285(6344):796-7. doi: 10.1136/bmj.285.6344.796.
5
Hemodynamic effects of an inhaled beta-2 agonist.
Clin Pharmacol Ther. 1984 Jun;35(6):762-7. doi: 10.1038/clpt.1984.108.
6
Trends in sales of drugs for asthma in New Zealand, Australia, and the United Kingdom, 1975-81.
Br Med J (Clin Res Ed). 1984 Aug 11;289(6441):348-51. doi: 10.1136/bmj.289.6441.348.
7
Systolic time intervals: a review of the method in the non-invasive investigation of cardiac function in health, disease and clinical pharmacology.
Postgrad Med J. 1983 Jul;59(693):423-34. doi: 10.1136/pgmj.59.693.423.
8
Beta 2-adrenoceptors mediate the stimulating effect of adrenaline on active electrogenic Na-K-transport in rat soleus muscle.
Br J Pharmacol. 1980 Apr;68(4):749-55. doi: 10.1111/j.1476-5381.1980.tb10868.x.
9
Investigation into use of drugs preceding death from asthma.
Br Med J. 1968 Feb 10;1(5588):339-43. doi: 10.1136/bmj.1.5588.339.
10
The role of cardiac beta-1 receptors in the hemodynamic response to a beta-2 agonist.
Clin Pharmacol Ther. 1986 Jul;40(1):108-15. doi: 10.1038/clpt.1986.146.
Zotero 插件